TILATAMIG

UNII:	Y5RC3BF6LQ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TILATAMIG
GSRS Full Record:	Y5RC3BF6LQ i

2868265-50-1
Immunoglobulin G1 [133-cysteine,227-valine,241-phenylalanine,242-glutamic acid,338-serine,361-cysteine,373-tryptophan], anti-(human epidermal growth factor receptor) (human monoclonal RAA22 γ1-chain), (133→126′′)-disulfide with [126-cysteine,216-valine] human monoclonal RAA22 λ-chain, (233→225′),(236→228′),(361→348′)-tris(disulfide) with immunoglobulin G1 [233-phenylalanine,234-glutamic acid,330-serine,348-cysteine,365-serine,367-alanine,406-valine] anti-(human hepatocyte growth factor receptor C-Met) (human monoclonal B09 γ1-chain) disulfide with human monoclonal B09 κ-chain
TILATAMIG [USAN]
Tilatamig
immunoglobulin G1-kappa/G1-lambda, anti-[Homo sapiens MET (met proto-oncogene, hepatocyte growth factor (HGF) receptor, HGFR, scatter factor (SF) receptor, HGF/SF receptor, receptor tyrosine-protein kinase c-met, papillary renal cell carcinoma 2, RCCP2)] and anti-[Homo sapiens EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB)], Homo sapiens monoclonal antibody, bispecific
tilatamig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TILATAMIG

Synonyms and Mappings

Resources